H
Harvest
Tax-loss replacement research
EXEL
Exelixis
Health CareBiotechnologyBiotechnology
28 stocks · 12 ETFs
data as of Aug 24, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for EXEL

Among the 28 Biotechnology peers screened, INCY (Incyte) has tracked EXEL most closely over the past year, with a return correlation of 0.46. The strongest fund stand-in is IBB (iShares Biotechnology ETF) at 0.49 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
INCYIncyteBiotechnology0.460.280.300.39
NBIXNeurocrine BiosciencesBiotechnology0.460.310.330.38
AMGNAmgen Inc.Biotechnology0.370.200.210.30
ROIVRoivant SciencesBiotechnology0.320.250.21
HRMYHarmony Biosciences Holdings, Inc.Biotechnology0.320.110.18
REGNRegeneron PharmaceuticalsBiotechnology0.310.240.230.33
VRTXVertex PharmaceuticalsBiotechnology0.310.200.230.33
TGTXTG Therapeutics, Inc.Biotechnology0.300.200.250.25
HALOHalozymeBiotechnology0.300.190.260.36
BIIBBiogen Inc.Biotechnology0.270.220.250.26
GILDGilead SciencesBiotechnology0.260.210.210.24
BMRNBioMarin PharmaceuticalBiotechnology0.250.170.240.34
ALNYAlnylam PharmaceuticalsBiotechnology0.250.180.210.31
SRPTSarepta TherapeuticsBiotechnology0.250.140.180.25
LGNDLigand Pharmaceuticals, Inc.Biotechnology0.230.180.250.29
XNCRXencor IncBiotechnology0.230.180.240.33
VIRVir Biotechnology, Inc.Biotechnology0.220.190.180.13
PTGXProtagonist Therapeutics, Inc.Biotechnology0.200.180.180.16
RGENRepligenBiotechnology0.200.160.210.26
KRYSKrystal BiotechBiotechnology0.200.200.190.20
VCELVericelBiotechnology0.180.160.250.23
MRNAModerna Inc.Biotechnology0.160.130.140.13
RCUSArcus Biosciences, Inc.Biotechnology0.160.190.240.26
FTREFortreaBiotechnology0.160.140.13
ARWRArrowhead PharmaceuticalsBiotechnology0.160.170.250.24
CYTKCytokineticsBiotechnology0.160.120.200.24
UTHRUnited TherapeuticsBiotechnology0.130.150.160.28
ADMAADMA Biologics, Inc.Biotechnology0.100.120.180.18
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.490.360.410.51
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.430.340.420.53
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.380.280.340.42
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.380.280.340.42
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.370.270.320.40
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.360.270.330.43
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.340.250.300.37
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.330.310.380.45
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.300.250.300.39
ARKGARK Genomic Revolution ETFGenomics (Active)INDUSTRY0.250.220.300.38
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY0.220.170.230.32
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.150.180.260.32
NEXT STEPS

Harvesting a loss in EXEL?

RELATED

Replacement research for EXEL's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.